General Federal Contracts — March 20, 2026

$881M obligations to Techflow (EDS maintenance, $512M) and BCCG JV (border barrier, $368M) with $344M outlayed show strong commitment to aviation security and border infrastructure.

$647M+ direct HHS awards (Deloitte NIH IT $468M, CGS Medicare $93M, Spectral MD R&D $87M) plus $270M ORR services via DOI, with $499M outlayed, indicate sustained health/IT spending.

$540M in water/refugee projects to Jacobs ($270M) and Providencia ($270M), with $265M outlayed and options to $764M, signal multi-year construction revenue.

Buchanan & Edwards $97M Job Corps IT at 87% outlayed ($85M) through 2026 underscores reliable T&M cash flow in federal labor services.

Long tenures (5-7 years to 2030) across 7/8 contracts with partial outlays (e.g., Techflow 67% of $512M) expose to delays, funding cliffs, or option non-exercises.

Firm fixed-price structures in 4 contracts (Techflow, BCCG, Jacobs, Deloitte) vulnerable to cost inflation in maintenance/construction.

High subawards (e.g., Deloitte $231M/49%, Jacobs $125M) reduce prime retention; full/open competition wins may face renewals pressure post-2026-2030.

$3B+ unexercised options (e.g., Techflow $1.6B to $2.15B total, CGS $120M, Providencia $214M) could double values through 2030.

Follow-on potential in DHS/HHS from full competition wins (e.g., TSA EDS, NIH IT, BARDA R&D, CBP border).

Minority-owned winners (Providencia, Buchanan) with $368M obligations offer ESG-aligned federal exposure.

$881M in aviation EDS and border barriers underscores priority on border/airport resilience.

$918M across IT upgrades, Medicare ops, refugee services, and burn imaging R&D shows sustained health tech investment.

$540M in water plants and sponsor services provides construction/services hedge against cyclical infra.

{"entity"=>"TECHFLOW, INC.", "reason"=>"Largest award ($513M obligation, $2.16B ceiling) with 67% outlayed; DHS EDS PBL leader.", "trigger"=>"$512M full obligation + option exercises"}

{"entity"=>"BCCG A JOINT VENTURE", "reason"=>"$368M border barrier (0% outlayed, award 9/2025) as future-dated catalyst in DHS infra.", "trigger"=>"initial outlays post-2026 start"}

{"entity"=>"SPECTRAL MD, INC.", "reason"=>"Small biz $87M BARDA R&D (57% outlayed to 2030) with biotech imaging upside.", "trigger"=>"option exercises or commercialization milestones"}